Kurma Partners

Kurma Growth Opportunities Fund is a Kurma Partners venture capital growth fund backing life sciences and healthcare companies raising growth capital. It focuses on late-stage, crossover and public rounds across therapeutics, diagnostics, HealthTech and opportunistic MedTech, with a majority focus in Europe and additional activity outside Europe. The €167 million fund closed in 2024 and has acted as a co-lead investor in Series B financing, making it relevant for later-stage biotech, pharma, oncology, diagnostics, HealthTech and medical device companies.